4//SEC Filing
Vale Brad 4
Accession 0001567619-21-005535
CIK 0001444380other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:41 PM ET
Size
11.3 KB
Accession
0001567619-21-005535
Insider Transaction Report
Form 4
NEVRO CORPNVRO
Vale Brad
Director
Transactions
- Sale
Common Stock
2021-03-01$166.05/sh−503$83,524→ 11,831 total - Sale
Common Stock
2021-03-01$167.04/sh−2,012$336,090→ 9,819 total - Sale
Common Stock
2021-03-01$168.32/sh−1,278$215,108→ 8,541 total - Sale
Common Stock
2021-03-01$169.08/sh−1,510$255,317→ 7,031 total
Footnotes (6)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $165.49 to $166.405, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 1,376 restricted stock units.
- [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $166.64 to $167.15, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $167.86 to $168.767, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $168.905 to $169.68, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
NEVRO CORP
CIK 0001444380
Entity typeother
Related Parties
1- filerCIK 0001635670
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:41 PM ET
- Size
- 11.3 KB